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what or very much affected their performance at work. In our multivariate logistic 
regression model examining change in employment status, the number of hours/
week of caregiving, use of support services, a PHQ-2 depression score of 4+, caring 
for a spouse, younger age and lower income were statistically significant. In our 
analysis examining change in work performance, the number of hours/week of 
caregiving, use of support services, PHQ-2 score of 4+, providing assistance with 
greater number of ADLs and greater number of IADLs, and younger age were signifi-
cant. ConClusions: Informal caregivers report high levels of change in employ-
ment and performance. Caregiver burden and the presence of depressive symptoms 
were strongly associated with a change in employment status and work perfor-
mance as a result of caregiving. Efforts aimed at identifying high levels of caregiver 
burden and depressive symptoms among caregivers may potentially have an impact 
on employment for some caregivers.
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objeCtives: Little is known about the real-world utilization and cost outcomes 
associated with different treatment modalities for opioid dependence. This study 
sought to analyze pre- and post-treatment cost and service utilization data from 
a multi-site, retrospective, naturalistic study of opioid dependent adults in three 
Pennsylvania residential rehabilitation programs. Methods: De-identified ret-
rospective electronic data on 7,687 patients treated in one of three residential 
treatment centers in Pennsylvania were linked with Medicaid administrative 
data. Duration of Medicaid supported treatment and relative Medicaid costs and 
treatment patterns were compared across 4 different treatment modalities: 1) 
extended-release naltrexone (XR-NTX), 2) agonist (methadone), 3) partial agonist 
(buprenorphine), and 4) drug-free treatment. Costs and utilization patterns in the 
immediate phase after discontinuation were also compared. Results: XR-NTX-
treated (vs. non-medicated) patients were half as likely (odds ratio [OR] 0.47; 95%CI 
0.22-1.00; p< 0.05) to leave against medical advice (AMA), three times more likely 
to complete rehab (OR 3.26; 95% CI 1.70-6.23; p< .01) and twice as likely to initiate 
follow-up treatment within 7-10 days (OR 1.92; 95% CI 1.33-2.77; p< .01). Among the 
4,311 patients for whom Medicaid data were available, costs among XR-NTX treated 
patients were lower than for a non-XR-NTX treated comparison group in the month 
following treatment discontinuation ($1,463 vs. $1,613). ConClusions: Although 
the study is limited due to non-randomization and retrospective administrative 
data, it represents real-world clinical experience and health care spending costs. 
Patients receiving XR-NTX were less likely to leave residential treatment AMA, more 
likely to initiate follow-up treatment, and had lower Medicaid costs in the month 
following treatment discontinuation.
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objeCtives: Children and adolescents with severe behavioral health problems 
are often treated with complex psychoactive medication regimens with unclear 
diagnostic and treatment history, amplified by sporadic and often poorly-coordi-
nated treatment. Recently, the use of antipsychotic medications in children has 
grown substantially among DMA enrollees and now constitutes $44.4 million in 
pharmacy reimbursement costs annually. Methods: Policy was developed that 
required prescribers to register patients via A+KIDS, a web portal, when prescrib-
ing antipsychotics in patients under 18 years old before the medication could be 
approved for pharmacy reimbursement. Required registration elements included a 
patient’s primary diagnosis, target symptom, initiating prescriber, caregiver support 
of medication use, adverse drug events, and metabolic monitoring deemed best 
practice. A+KIDS registry data, including children age 17 and under data, were used 
to examine the first two years of the registry. Results: A total of 1650 providers 
made 51346 requests for 20434 patients in the first two years of the registry. The 
most commonly requested drug was Risperidone (40.68% of the requests). “Bipolar 
Disorder,” “ADHD,” and “Oppositional Defiant Disorder” were the three most com-
mon diagnoses (33.76%). “Aggression towards others,” “Irritability” and “Tantrums/
temper” were the most common target symptoms (62.12%). Over half (52.48%) of the 
medications were first prescribed by an outpatient psychiatrist. Glucose monitor-
ing increased from 52% to 64% and lipid monitoring from 27% to 46% for children 
on antipsychotics. ConClusions: Most prescribers of antipsychotics in children 
were enthusiastic about participating in the prescribing registry, expressing con-
cern about prescribing in an ill-coordinated environment with high risk of serious 
adverse events and long term side effects. Asking prescribers about glucose and lipid 
values increased monitoring significantly with implementation of the registry. The 
registry has the potential for increasing awareness about the effects and usefulness 
of these medicines by enhancing claims data with clinical data.
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objeCtives: Prescription Drug Monitoring Programs (PDMPs) have been enacted 
by several states to combat the abuse and diversion of controlled substances (CS). 
reduced HRQoL, especially physical component score, in elderly dementia patients. 
The study findings suggest the need to evaluate anticholinergic burden, and if pos-
sible, use of these potentially inappropriate agents should be avoided in the vulner-
able dementia patients.
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objeCtives: We examined Health-Related Quality of Life (HRQoL) of adoles-
cents and adults with Down syndrome (DS) and test-retest reliability of the 
KIDSCREEN-27. Methods: We conducted a multi-lingual, non-drug, longitudinal 
study in 8 countries. Sixty-one participants were included (30 males, 31 females). 
Assessments were performed at baseline and week 24. The KIDSCREEN-27 Parent-
Form uses a 5-point Likert scale and comprises five domains: Physical Wellbeing 
(range 5-25), Psychological Wellbeing (range 7-35), Autonomy & Parent Relations 
(range 7-35), Peers & Social Support (range 4-20), and School Environment (range 
4-20). Higher scores indicate improved HRQoL. A clinician global rating of improve-
ment (ranging from 1 ‘very much improved’ to 7 ‘very much worse’) was used to 
assess participant clinical status. Intra-class correlations for participants rated 
as “no change” were calculated to assess test-retest reliability of the KIDSCREEN 
between baseline and week 24. Results: The average age was 14 years and 23 
years in adolescents (N= 34) and adults (N= 27), respectively. The following base-
line KIDSCREEN raw scores were obtained for adolescents and adults respectively: 
Physical Wellbeing 17.4 ± 3.65 and 15.5 ± 2.94; Psychological Wellbeing 28.1 ± 3.65 
and 28.4 ± 4.02; Autonomy and Parent Relations 26.0 ± 4.92 and 28.4 ± 4.16; Peers and 
Social Support 12.1 ± 3.74 and 13.6 ± 4.14; School Environment 15.4 ± 2.41 and 15.6 ± 
2.08. Thirty-five respondents were deemed stable. The KIDSCREEN-27 showed fair to 
good test-retest reliability (range ICC 0.44 to 0.76) with the exception of Autonomy 
and Parent Relations (-0.16) and Psychological Wellbeing (0.19) in adolescents, and 
Physical Wellbeing (0.32) and School Environment (0.30) in adults. ConClusions: 
At baseline both adolescents and adults displayed a reasonable HRQoL as measured 
by the KIDSCREEN-27. Test-retest reliability may have been influenced by the long 
timeframe between the two assessments.
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objeCtives: Opioid dependence not only impacts health outcomes and health 
care costs in the US, but also imposes a large economic burden on the workplace. 
Estimated lost workplace productivity accounts for the largest share (~$25.6 billion 
or 45.6%) of total societal costs.41This study evaluated the impact of extended-
release naltrexone (XR-NTX), available as a once-monthly injectable treatment 
option for preventing relapse to opioid dependence, on self-reported substance 
use and employment status, in patients treated in a real-world, naturalistic 
study. Methods: Analysis of an open-label, single-arm, US multicenter registry of 
adult, opioid dependent outpatients initiating XR-NTX treatment following detoxifi-
cation. Substance use and employment status in the previous 28 days were collected 
via the National Treatment Agency Treatment Outcomes Profile (TOP). Analyses were 
conducted in patients with data available from baseline until at least 6 months of 
XR-NTX treatment. Intra-subject paired hypothesis tests were conducted. Results: 
A total of 112 (26.6%) of 403 enrolled registry patients had over 6 months of on-
treatment follow-up, with 99 (24.6%) completing Month 6 assessments. Abstinence 
rates for opioids (45.5% to 95.0%; p= 0.001), alcohol (64.7% to 78.8%; p= 0.006), and 
stimulants (crack, cocaine and amphetamine) (82.8% to 96.0%; p= 0.002) signifi-
cantly increased from baseline to Month 6. Baseline to Month 6 unemployment 
rates significantly decreased from 53.5% to 37.4% (p= 0.005). Among 53 patients 
unemployed at baseline, the majority (55.3%) reported employment at Month 6, 
with 17.0% indicating working 1-16 days and 28.3% working > 16 days in the prior 
28 days. ConClusions: In this real-world registry, XR-NTX was associated with 
increased rates of opioid abstinence, as demonstrated in previous controlled stud-
ies. While limitations include the uncontrolled design and the sample subset with 
6 months of data, this is the first study to find that patients in XR-NTX treatment 
showed reductions in overall drug use, with concurrent increased employment.
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objeCtives: The objective of this study was to identify factors associated with a 
change in work performance (Model #1) and with a change in employment sta-
tus (Model #2) among informal caregivers. We hypothesized caregiver burden and 
caregiver mental health were key potentially modifiable characteristics of these 
two outcomes. Methods: A representative (U.S.) sample of 705 adult caregivers 
completed an online survey regarding their role as an informal caregiver and its 
impact on their employment. Model II examined 544 of the 705 respondents due 
to missing data. We conducted bivariate analyses and used multivariate logistic 
regression to assess the impact of caregiver burden, caregiver mental and physical 
health, caregiver relationship, and use of caregiving support services on: a change 
in work performance and a change in employment status. Sociodemographic vari-
ables were also examined. Results: 32% (n= 176) of caregivers reported being laid 
off or resigned from their position while 46% (n= 322) reported caregiving some-
